These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 22664560)

  • 21. Early changes in incretin secretion after laparoscopic duodenal-jejunal bypass surgery in type 2 diabetic patients.
    Lee HC; Kim MK; Kwon HS; Kim E; Song KH
    Obes Surg; 2010 Nov; 20(11):1530-5. PubMed ID: 20803098
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human duodenal enteroendocrine cells: source of both incretin peptides, GLP-1 and GIP.
    Theodorakis MJ; Carlson O; Michopoulos S; Doyle ME; Juhaszova M; Petraki K; Egan JM
    Am J Physiol Endocrinol Metab; 2006 Mar; 290(3):E550-9. PubMed ID: 16219666
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of Great Curvature Plication with Duodenal-Jejunal Bypass (GCP-DJB) and Sleeve Gastrectomy (SG) on Metabolic Indices and Gut Hormones in Type 2 Diabetes Mellitus Rats.
    Qiu NC; Li W; Liu ME; Cen XX; Shan CX; Zhang W; Liu Q; Wang Y; Zhu YT; Qiu M
    Obes Surg; 2018 Dec; 28(12):4014-4021. PubMed ID: 30109670
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The enteroinsular axis and the recovery from type 2 diabetes after bariatric surgery.
    Patriti A; Facchiano E; Sanna A; Gullà N; Donini A
    Obes Surg; 2004; 14(6):840-8. PubMed ID: 15318993
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beneficial Metabolic Effects of Duodenal Jejunal Bypass Liner for the Treatment of Adipose Patients with Type 2 Diabetes Mellitus: Analysis of Responders and Non-Responders.
    Stratmann B; Krepak Y; Schiffer E; Jarick I; Hauber M; Lee-Barkey YH; Fischer M; Tschoepe D
    Horm Metab Res; 2016 Sep; 48(10):630-637. PubMed ID: 27589345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preserving Duodenal-Jejunal (Foregut) Transit Does Not Impair Glucose Tolerance and Diabetes Remission Following Gastric Bypass in Type 2 Diabetes Sprague-Dawley Rat Model.
    Dolo PR; Yao L; Li C; Zhu X; Shi L; Widjaja J
    Obes Surg; 2018 May; 28(5):1313-1320. PubMed ID: 29098544
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Analogs of glucagon-like peptide-1 (GLP-1): an old concept as a new treatment of patients with diabetes mellitus type 2].
    Diamant M; Bunck MC; Heine RJ
    Ned Tijdschr Geneeskd; 2004 Sep; 148(39):1912-7. PubMed ID: 15495988
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The entire small intestine mediates the changes in glucose homeostasis after intestinal surgery in Goto-Kakizaki rats.
    Liu S; Zhang G; Wang L; Sun D; Chen W; Yan Z; Sun Y; Hu S
    Ann Surg; 2012 Dec; 256(6):1049-58. PubMed ID: 23001083
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in insulin resistance following bariatric surgery: role of caloric restriction and weight loss.
    Gumbs AA; Modlin IM; Ballantyne GH
    Obes Surg; 2005 Apr; 15(4):462-73. PubMed ID: 15946423
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The entero-insular axis in type 2 diabetes--incretins as therapeutic agents.
    Creutzfeldt W
    Exp Clin Endocrinol Diabetes; 2001; 109 Suppl 2():S288-303. PubMed ID: 11460578
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ileal transposition controls diabetes as well as modified duodenal jejunal bypass with better lipid lowering in a nonobese rat model of type II diabetes by increasing GLP-1.
    Wang TT; Hu SY; Gao HD; Zhang GY; Liu CZ; Feng JB; Frezza EE
    Ann Surg; 2008 Jun; 247(6):968-75. PubMed ID: 18520224
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patients with neuroglycopenia after gastric bypass surgery have exaggerated incretin and insulin secretory responses to a mixed meal.
    Goldfine AB; Mun EC; Devine E; Bernier R; Baz-Hecht M; Jones DB; Schneider BE; Holst JJ; Patti ME
    J Clin Endocrinol Metab; 2007 Dec; 92(12):4678-85. PubMed ID: 17895322
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic administration of alogliptin, a novel, potent, and highly selective dipeptidyl peptidase-4 inhibitor, improves glycemic control and beta-cell function in obese diabetic ob/ob mice.
    Moritoh Y; Takeuchi K; Asakawa T; Kataoka O; Odaka H
    Eur J Pharmacol; 2008 Jul; 588(2-3):325-32. PubMed ID: 18499100
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diabetes recurrence after metabolic surgeries correlates with re-impaired insulin sensitivity rather than beta-cell function.
    Liu T; Zhong MW; Liu Y; Sun D; Wei M; Huang X; Cheng YG; Wu QZ; Wu D; Zhang XQ; Wang KX; Hu SY; Liu SZ
    World J Gastroenterol; 2017 May; 23(19):3468-3479. PubMed ID: 28596682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of the dipeptidyl peptidase-IV inhibitor vildagliptin on incretin hormones, islet function, and postprandial glycemia in subjects with impaired glucose tolerance.
    Rosenstock J; Foley JE; Rendell M; Landin-Olsson M; Holst JJ; Deacon CF; Rochotte E; Baron MA
    Diabetes Care; 2008 Jan; 31(1):30-5. PubMed ID: 17947341
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Different incretin responses after pancreatoduodenectomy and distal pancreatectomy.
    Mori Y; Ohtsuka T; Tsutsumi K; Yasui T; Ueda J; Takahata S; Nakamura M; Tanaka M
    Pancreas; 2012 Apr; 41(3):455-60. PubMed ID: 22422137
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intestinal adaptation and Reg gene expression induced by antidiabetic duodenal-jejunal bypass surgery in Zucker fatty rats.
    Li B; Lu Y; Srikant CB; Gao ZH; Liu JL
    Am J Physiol Gastrointest Liver Physiol; 2013 Apr; 304(7):G635-45. PubMed ID: 23370676
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exclusion of the Distal Ileum Cannot Reverse the Anti-Diabetic Effects of Duodenal-Jejunal Bypass Surgery.
    Chai J; Zhang G; Liu S; Hu C; Han H; Hu S; Zhang Z
    Obes Surg; 2016 Feb; 26(2):261-8. PubMed ID: 26024737
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alterations in gut microbiota during remission and recurrence of diabetes after duodenal-jejunal bypass in rats.
    Zhong MW; Liu SZ; Zhang GY; Zhang X; Liu T; Hu SY
    World J Gastroenterol; 2016 Aug; 22(29):6706-15. PubMed ID: 27547013
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduced glucose tolerance and insulin resistance induced by steroid treatment, relative physical inactivity, and high-calorie diet impairs the incretin effect in healthy subjects.
    Hansen KB; Vilsbøll T; Bagger JI; Holst JJ; Knop FK
    J Clin Endocrinol Metab; 2010 Jul; 95(7):3309-17. PubMed ID: 20410219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.